ERBB2 and breast carcinoma: Breast cancer can be divided into several molecular subtypes based on gene expression profiling analysis, which are subsequently corroborated by a panel of immunohistochemical (IHC) markers including ER, progesterone receptor (PR), human epidermal growth receptor factor 2 (HER2), proliferation marker Ki-67, cytokeratin (CK) 5/6, and epidermal growth factor receptor (EGFR).